Companion Diagnostics and Lab Services
From biomarker discovery to companion diagnostic—and the network to deploy it
Tempus operates one of the most comprehensive precision medicine labs in oncology, with FDA authorized assays, a full multi-omics menu, and a commercial network of 7,500+ oncologists.
One platform, three reinforcing capabilities
Sequencing
A clinical-grade NGS portfolio—solid tumor, heme, liquid biopsy, exome, transcriptome, MRD—run out of CAP-accredited, CLIA-certified labs with a fast turnaround time.
Companion Diagnostics
A data-driven CDx development partnership backed by FDA authorized assays (xT CDx, xR IVD) and CMS ADLT status.
Omics Solutions
Disease-agnostic, high-throughput multi-omics—genotyping, methylation, proteomics, single-cell, spatial transcriptomics—with PhD-level analytical support and white-glove project management.
Proof in outcomes
95%
of the top 20 pharma companies partner with Tempus
7.5K+
oncologists rely on Tempus as a precision medicine partner
250+
biopharma partnerships
This is AI-enabled precision medicine
This is the future of healthcare.